Home » Newsletters » BioWorld Asia

BioWorld Asia

Sep. 21, 1999

View Archived Issues

U.S. Official Blasts EU Leaders On Their Approach To Biotech

Privately Held CeNeS Proposes Reverse Merger With Core Group

Retraining Might Be Necessary To Supplement Cell Transplants

Arcoda Plans To Use Financing To Invest In Start-Up Companies

EuropaBio Decries Report On Control Of GM Seeds Industry

Companies Flock To Ginoptle, The 'Genetics Valley' of France

German Agency Founded To Focus Solely On Biotechnology

German Consortium Started To Link Genomics Information

Australian Researchers Plan Late-Stage Study For Warts

French Corn Producers Say Biotech Needed To Compete

XTL's Animal Model For HCV Licensed For Testing By Lilly

Evotec Cancels Initial Offering Due To Conditions In Germany

Vanguard Sings On Distributor In Europe For Migraine Drug

Transghne Starts First Study Of MVA-HPV Cancer Vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...